The current invention relates to a method for the determination of the risk of pathologies in a population of women colonized by the
Gardnerella vaginalis
bacterium, comprising the following steps in order:
a) determination of the IgA and/or IgG and/or IgM antibody levels against Gvh toxin secreted by
G. vaginalis
in a sample of body fluid;
b) comparison of said levels of IgA and/or IgG and/or IgM with predeterminate levels of IgA and/or IgG and/or IgM, respectively;
c) determination of the risk factor.
Said method resulted particularly efficient in permitting to obtain an accurate and reliable evaluation of the risk of pathologies related to the colonization by the bacterium
G. vaginalis
in women. Consequently, this method gives the physician an effective tool to decide whether or not to administer a pharmacological therapy.
本发明涉及一种方法,用于确定被阴道加德纳菌定植的妇女群体的病变风险。
阴道加德纳菌
该方法依次包括以下步骤:
a) 测定针对阴道加德纳菌分泌的 Gvh 毒素的 IgA 和/或 IgG 和/或 IgM
抗体水平,包括
阴道加德纳菌
体液样本中针对阴道杆菌分泌的 Gvh 毒素的 IgA 和/或 IgG 和/或 IgM
抗体水平
b) 将上述 IgA 和/或 IgG 和/或 IgM
水平分别与预先确定的 IgA 和/或 IgG 和/或 IgM
水平进行比较;
c) 确定风险因素。
该方法特别有效,能准确可靠地评估与阴道杆菌定植有关的病理风险。
阴道杆菌
的风险。因此,这种方法为医生提供了一个有效的工具来决定是否进行药物治疗。